Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising -- Ignore unavailable to you. Want to Upgrade?

To: Russian Bear who wrote (132)	10/23/1997 4:41:00 AM
From: Czechsinthemail	Read Replies (1) \| Respond to of 496

Many if not most stock buybacks are announced for the psychological lift they can bring to the stock. If they are smart, they can sell puts rather than buy shares outright. This increases income/decreases share cost on any purchases. If Amgen goes this route, they can acquire a lot of stock and have lots of cash to spare. I think Amgen's need to get something to fill their pipeline is very beneficial for GLFD, and an accelerated R&D schedule certainly can't be ruled out. Baird